REVIEW LITERATUR: PENTINGNYA DIAGNOSIS AWAL KARDIOMIOPATI PERIPARTUM

Sindhu Wisesa, Aristi Intan Soraya

Sari


Abstrak: Review Literatur: Pentingnya Diagnosis awal Kardiomiopati
Peripartum. Kardiomiopati peripartum (KMPP) merupakan penyakit yang ditandai
dengan penurunan fungsi sistolik ventrikel kiri pada akhir kehamilan atau setelah
melahirkan. Pasien KMPP seringkali mengunjungi fasilitas kesehatan dengan
komplikasi dan penurunan fungsi jantung yang nyata sehingga sulit untuk
ditangani. Kasus KMPP masih sering underdiagnosis karena memiliki gejala yang
mirip dengan gagal jantung akibat etiologi lain, dan pada kasus yang ringan
menyerupai perubahan fisiologis pada kehamilan. Penanganan awal KMPP dengan
fungsi sistolik ventrikel kiri yang masih baik berhubungan dengan pemulihan yang
lebih baik dan komplikasi yang rendah. Oleh karena itu, kesadaran pentingnya
diagnosis awal penyakit KMPP pada masyarakat dan tenaga kesehatan perlu
ditingkatkan agar dapat dilakukan terapi dini KMPP, sehingga menurunkan
morbiditas dan mencegah kematian ibu.


Kata Kunci


diagnosis awal; gagal jantung; kardiomiopati peripartum; kehamilan

Teks Lengkap:

PDF

Referensi


Arany, Z. and Elkayam, U. (2016) ‘Peripartum cardiomyopathy’, Circulation, 133(14), pp. 1397–1409. Available at: https://doi.org/10.1161/CIRCULATIONAHA.115.020491.

Arfianda, D., Wicaksono, B., Gumilar, K.E. and Andrianto, A. (2019) ‘Characteristics of Peripartum Cardiomyopathy (PPCM) pregnancy and preeclampsia in Dr Soetomo Hospital, Surabaya, Indonesia, 2014-2016’, Majalah Obstetri & Ginekologi, 27(1), p. 40. Available at: https://doi.org/10.20473/mog.v1i12019.40-44.

Barasa, A., Rosengren, A., Sandström, T.Z., Ladfors, L. and Schaufelberger, M. (2017) ‘Heart Failure in Late Pregnancy and Postpartum: Incidence and Long-Term Mortality in Sweden From 1997 to 2010’, Journal of Cardiac Failure, 23(5), pp. 370–378. Available at: https://doi.org/10.1016/j.cardfail.2016.12.011.

Bauersachs, J., König, T., van der Meer, P., Petrie, M.C., Hilfiker-Kleiner, D., Mbakwem, A., et al. (2019) ‘Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy’, European Journal of Heart Failure, 21(7), pp. 827–843. Available at: https://doi.org/10.1002/ejhf.1493.

Biteker, M., Ilhan, E., Biteker, G., Duman, D. and Bozkurt, B. (2012) ‘Delayed recovery in peripartum cardiomyopathy: An indication for long-term follow-up and sustained therapy’, European Journal of Heart Failure, 14(8), pp. 895–901. Available at: https://doi.org/10.1093/eurjhf/hfs070.

Cahya Febrimulya, D. and Wicaksono, B. (2021) ‘Peripartum Cardiomyopathy in Pregnancy with Severe Preeclampsia : A Cross-Sectional Study in A Tertiary Hospital’, International Journal of Research Publications, 84(1), pp. 152–156. Available at: https://doi.org/10.47119/ijrp100841920212234.

Chee, K.-H. (2013) ‘Favourable outcome after peripartum cardiomyopathy: A ten-year study on peripartum cardiomyopathy in a university hospital’, Singapore Medical Journal, 54(1), pp. 28–31. Available at: https://doi.org/10.11622/smedj.2013007.

Damp, J., Givertz, M.M., Semigran, M., Alharethi, R., Ewald, G., Felker, G.M., et al. (2016) ‘Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy. Results of the Multicenter IPAC Study.’, JACC: Heart Failure, 4(5), pp. 380–388. Available at: https://doi.org/10.1016/j.jchf.2016.01.004.

Davis, C.R., Bates, A.S., Ellis, H. and Roberts, A.M. (2014) ‘Human anatomy: Let the students tell us how to teach’, Anatomical Sciences Education, 7(4), pp. 262–272. Available at: https://doi.org/10.1002/ase.1424.

Davis, M.B., Arany, Z., McNamara, D.M., Goland, S. and Elkayam, U. (2020) ‘Peripartum Cardiomyopathy: JACC State-of-the-Art Review’, Journal of the American College of Cardiology, 75(2), pp. 207–221. Available at: https://doi.org/10.1016/j.jacc.2019.11.014.

Desai, D., Moodley, J. and Naidoo, D. (1995) ‘Peripartum Cardiomyopathy: Experiences at King Edward VIII Hospital, Durban, South Africa and a Review of the Literature’, Tropical Doctor, 25(3), pp. 118–123. Available at: https://doi.org/10.1177/004947559502500310.

Dröge, L., Herraiz, I., Zeisler, H., Schlembach, D., Stepan, H., Küssel, L., et al. (2015) ‘Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies’, Ultrasound in Obstetrics and Gynecology, 45(3), pp. 286–293. Available at: https://doi.org/10.1002/uog.14760.

Ersbøll, A.S., Johansen, M., Damm, P., Rasmussen, S., Vejlstrup, N.G. and Gustafsson, F. (2017) ‘Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome’, European Journal of Heart Failure, 19(12), pp. 1712–1720. Available at: https://doi.org/10.1002/ejhf.882.

Febrimulya, D.C. and Wicaksono, B. (2021) ‘Peripartum Cardiomyopathy in Pregnancy with Severe Preeclampsia : A Cross-Sectional Study in A Tertiary Hospital’, International Journal of Research Publications, 84(1), pp. 152–156. Available at: https://doi.org/10.47119/ijrp100841920212234.

Fett, J.D., Christie, L.G., Carraway, R.D. and Murphy, J.G. (2005) ‘Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution’, Mayo Clinic Proceedings, 80(12), pp. 1602–1606. Available at: https://doi.org/10.4065/80.12.1602.

Halkein, J., Tabruyn, S.P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.Q.N., Scherr, M., et al. (2013) ‘MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy’, Journal of Clinical Investigation, 123(5), pp. 2143–2154. Available at: https://doi.org/10.1172/JCI64365.

Hilfiker-Kleiner, D., Kaminski, K., Podewski, E., Bonda, T., Schaefer, A., Sliwa, K., et al. (2007) ‘A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy’, Cell, 128(3), pp. 589–600. Available at: https://doi.org/10.1016/j.cell.2006.12.036.

Hoevelmann, J., Muller, E., Hohlfeld, A., Böhm, M., Sliwa, K., Engel, M.E., et al. (2021) ‘Outcomes and complications of peripartum cardiomyopathy: Protocol for a systematic review and meta-analysis’, BMJ Open, 11(10), pp. 1–8. Available at: https://doi.org/10.1136/bmjopen-2021-054994.

Honigberg, M.C., Cantonwine, D.E., Thomas, A.M., Lim, K.H., Parry, S.I. and Mcelrath, T.F. (2016) ‘Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia’, Journal of Perinatology, 36(3), pp. 172–177. Available at: https://doi.org/10.1038/jp.2015.170.

Honigberg, M.C. and Givertz, M.M. (2019) ‘Peripartum cardiomyopathy’, BMJ, 364, pp. 1–14. Available at: https://doi.org/10.1136/bmj.k5287.

Huang, G.Y., Zhang, L.Y., Long-Le, M.A. and Wang, L.X. (2012) ‘Clinical characteristics and risk factors for peripartum cardiomyopathy’, African Health Sciences, 12(1), pp. 26–31.

Isezuo, S.A. and Abubakar, S.A. (2007) ‘Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital.’, Ethnicity & disease, 17(2), pp. 228–233.

Kao, D.P., Hsich, E. and Lindenfeld, J.A. (2013) ‘Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy’, JACC: Heart Failure, 1(5), pp. 409–416. Available at: https://doi.org/10.1016/j.jchf.2013.04.011.

Karaye, K., Habib, A. and Sliwa, K. (2019) ‘Epidemiology of Peripartum Cardiomyopathy in Africa’, International Cardiovascular Forum Journal, 15(March). Available at: https://doi.org/10.17987/icfj.v15i0.545.

Kolte, D., Khera, S., Aronow, W.S., Palaniswamy, C., Mujib, M., Ahn, C., et al. (2014) ‘Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: A nationwide population-based study’, Journal of the American Heart Association, 3(3), pp. 1–13. Available at: https://doi.org/10.1161/JAHA.114.001056.

Kuć, A., Kubik, D., Męcik-Kronenberg, T., Kościelecka, K. and Szymanek, W. (2022) ‘The Relationship Between Peripartum Cardiomyopathy and Preeclampsia – Pathogenesis, Diagnosis and Management’, Journal of Multidisciplinary Healthcare, 15(March), pp. 857–867. Available at: https://doi.org/10.2147/JMDH.S357872.

Lee, S., Cho, G.J., Park, G.U., Kim, L.Y., Lee, T.S., Kim, D.Y., et al. (2018) ‘Incidence, Risk Factors, and Clinical Characteristics of Peripartum Cardiomyopathy in South Korea’, Circulation: Heart Failure, 11(4), pp. 1–8. Available at: https://doi.org/10.1161/CIRCHEARTFAILURE.117.004134.

Lewey, J., Levine, L.D., Elovitz, M.A., Irizarry, O.C. and Arany, Z. (2020) ‘Importance of Early Diagnosis in Peripartum Cardiomyopathy’, Hypertension, 75(1), pp. 91–97. Available at: https://doi.org/10.1161/HYPERTENSIONAHA.119.13291.

Mallikethi-Reddy, S., Akintoye, E., Trehan, N., Sharma, S., Briasoulis, A., Jagadeesh, K., et al. (2017) ‘Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations’, International Journal of Cardiology, 235, pp. 114–117. Available at: https://doi.org/10.1016/j.ijcard.2017.02.084.

McNamara, D.M., Elkayam, U., Alharethi, R., Damp, J., Hsich, E., Ewald, G., et al. (2015) ‘Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).’, Journal of the American College of Cardiology, 66(8), pp. 905–914. Available at: https://doi.org/10.1016/j.jacc.2015.06.1309.Clinical.

Pearson, G.D., Veille, J.C., Rahimtoola, S., Hsia, J., Oakley, C.M., Hosenpud, J.D., et al. (2000) ‘Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review.’, JAMA, 289(9), pp. 1183–1188. Available at: https://doi.org/https://doi.org/10.1001/jama.283.9.1183.

Phanaka, E.L., Iqbal, M. and Wiwaha, G. (2020) ‘Case Study on Cardiac Decompensation in Patients with Preeclampsia and Peripartum Cardiomyopathy’, Majalah Kedokteran Bandung, 52(1), pp. 53–60.

Rinta, F., Ketaren, I. and Wicaksono, A. (2016) ‘Gambaran Kardiomiopati Peripartum di Rumah Sakit Santo Antonius Pontianak Tahun 2008-2012’, Cerebellum, 2(1), pp. 345–359.

Sakamoto, A., Hosoya, N., Kageyama, S., Yoshizaki, T., Takeuchi, R., Murata, K., et al. (2014) ‘Peripartum cardiomyopathy with biventricular thrombus which led to massive cerebral embolism’, Journal of Cardiology Cases, 9(2), pp. 71–74. Available at: https://doi.org/10.1016/j.jccase.2013.10.002.

Setiantiningrum, M. and Rehatta, V. (2014) ‘Definisi, Etiopatogenesis, dan Diagnosis Kardiomiopati Peripartum’, Cermin Dunia Kedokteran 218, 41(7), pp. 492–496.

Sliwa, K., Petrie, M.C., Van Der Meer, P., Mebazaa, A., Hilfiker-Kleiner, D., Jackson, A.M., et al. (2020) ‘Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: An ESC EORP registry’, European Heart Journal, 41(39), pp. 3787–3797. Available at: https://doi.org/10.1093/eurheartj/ehaa455.

Ware, J.S., Li, J., Mazaika, E., Yasso, C.M., DeSouza, T., Cappola, T.P., et al. (2016) ‘Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies’, New England Journal of Medicine, 374(3), pp. 233–241. Available at: https://doi.org/10.1056/nejmoa1505517.

Wu, V.C.C., Chen, T.H., Yeh, J.K., Wu, M., Lu, C.H., Chen, S.W., et al. (2017) ‘Clinical outcomes of peripartum cardiomyopathy: A 15-year nationwide population-based study in Asia’, Medicine (United States), 96(43). Available at: https://doi.org/10.1097/MD.0000000000008374.




DOI: https://doi.org/10.33024/jikk.v10i4.9522

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc4.footer##

Pendidikan Dokter Universitas Malahayati Lampung


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.